ALT, serving as a nonspecific marker for hepatitis screening, is notably susceptible to influence from various physiological conditions and nonhepatic pathological factors, which may lead to false-positive results in donor screening [1–2]. The gene discussed is GPT; the disease is hepatitis A virus infection.